Live Breaking News & Updates on Randall Michael Giuffre

Stay updated with breaking news from Randall michael giuffre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Sees Significant Growth in Short Interest

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report) was the target of a large growth in short interest in July. As of July 15th, there was short interest totalling 796,100 shares, a growth of 11.6% from the June 30th total of 713,600 shares. Approximately 4.5% of the shares of the stock are sold short. Based […] ....

Randall Michael Giuffre , Catalyst Financial Partners , Dimensional Fund Advisors , Citadel Advisors , Renaissance Technologies , Diamedica Therapeutics Inc , Securities Exchange Commission , Diamedica Therapeutics , Get Free Report , Koch Thomas Von , Director Randall Michael Giuffre , Exchange Commission , Street Corp , Fund Advisors , Financial Partners , Medica Therapeutics , Medica Therapeutics Inc , Diamedica Therapeutics Daily , Nasdaq Dmac ,

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Director Purchases $254,150.00 in Stock

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) Director Randall Michael Giuffre acquired 65,000 shares of DiaMedica Therapeutics stock in a transaction that occurred on Friday, June 23rd. The shares were bought at an average price of $3.91 per share, with a total value of $254,150.00. Following the transaction, the director now directly owns 360,355 shares […] ....

Randall Michael Giuffre , Diamedica Therapeutics Company Profile , Renaissance Technologies , Dimensional Fund Advisors , Catalyst Financial Partners , Diamedica Therapeutics Inc , Citadel Advisors , Diamedica Therapeutics , Get Rating , Director Randall Michael Giuffre , Medica Therapeutics , Street Group , Financial Partners , Fund Advisors , Medica Therapeutics Inc , Diamedica Therapeutics Daily , Nasdaq Dmac , Insider Trading , Nsider Trades ,